Browse the evidence

Women diagnosed with breast cancer can safely consume soyfoods without increasing the risk of recurrence or mortality, and post-diagnosis soy intake may be associated with a decreased risk of recurrence.

If you have had breast cancer, you can eat soyfoods. They are safe and do not increase your risk of the cancer coming back. Some studies even suggest they might help, but you shouldn't start eating them just to treat the cancer—just include them as part of a healthy diet.

Encapsulation technologies (nanoencapsulation, cyclodextrins) can significantly increase the bioavailability of poorly bioactive polyphenols like quercetin and resveratrol by stabilizing them and facilitating transport across the mucus layer.

If you are considering high-dose polyphenol supplements, look for formulations that use encapsulation (like nanoparticles or cyclodextrins) as these are designed to overcome the body's natural barriers to absorption. However, for general health, prioritizing whole food sources is still recommended as they provide a complex matrix of nutrients.

High prevalence of modifiable risk factors, specifically smoking (50.4% active smokers) and alcohol consumption (72.4% regular consumers), are strongly associated with the high rates of chronic diseases like hypertension and hyperlipidemia in the Greek population.

More than half of Greek adults are active smokers and nearly three-quarters are regular alcohol consumers. These behaviors are major contributors to the high rates of hypertension and heart disease. Reducing smoking and alcohol intake are critical steps for improving public health outcomes, supported by policies that make these changes easier.

Cow milk consumption is associated with lower risk of mortality and major cardiovascular disease events, and can improve insulin resistance, particularly when derived from pasture-fed cows with higher CLA and n-3 PUFA content.

Incorporating cow milk, particularly from pasture-fed cows, can support cardiovascular health and insulin resistance. The benefits are linked to higher levels of CLA and n-3 fatty acids in pasture-fed milk. Choose high-quality dairy sources for maximum metabolic benefit.

Consumption of beef and bread products is independently associated with higher selenium levels, while consumption of white rice, eggs, coffee, and dairy products is associated with lower selenium levels.

Your diet affects your selenium levels. Eating more beef and bread products can help increase your selenium, while eating more white rice, eggs, coffee, and dairy might be associated with lower levels. To optimize your selenium, prioritize selenium-rich foods like beef, bread, and Brazil nuts, and consider the potential impact of high-glycemic foods like white rice on your oxidative stress.

Treating cardiovascular, kidney, and metabolic diseases as interconnected entities sharing common pathophysiological mechanisms (CKM syndrome) is superior to treating them as separate, isolated conditions.

If you have high blood pressure, high blood sugar, and kidney issues, do not treat them in isolation. Seek a care model that addresses all three simultaneously, as they likely stem from the same underlying metabolic and inflammatory drivers. This integrated approach is the current standard of care for preventing progression to heart failure or end-stage kidney disease.

Plant-based diets require higher total protein intake than the standard RDA to achieve equivalent amino acid utilization compared to mixed diets.

If you eat a plant-based diet, the standard protein recommendation might not be enough because plant proteins are harder for your body to use. You likely need to eat more total protein than the standard guideline suggests to maintain muscle and health. Focus on variety and ensure you are getting enough calories to meet these higher protein needs.

Post-exercise recovery of muscle function from eccentric damage is accelerated by a protein-polyphenol beverage, but this acceleration is not mechanistically explained by increased myofibrillar protein synthesis (MyoPS) or suppression of inflammatory/regenerative gene expression.

If you are recovering from intense eccentric exercise (like heavy lifting or downhill running), consuming a protein-polyphenol beverage may help you regain strength faster than a placebo. However, do not expect this to build more muscle or reduce inflammation more than standard recovery. The benefit is likely due to factors other than protein synthesis or inflammation control, such as improved cellular energy or signaling not measured here. Focus on consistent protein intake rather than specific 'anti-inflammatory' supplements for recovery speed.

In overweight adults with type 2 diabetes (BMI 25-29 kg/m2), long-term intentional weight loss is associated with slightly better mean global cognitive function compared to a control group.

If you are overweight (not obese) and have type 2 diabetes, long-term weight loss might actually support your cognitive health better than staying at your current weight. This is in contrast to obese patients, where weight loss was linked to cognitive decline. Focus on sustainable lifestyle changes that improve your overall health, and discuss cognitive monitoring with your doctor.

In patients newly diagnosed with type 2 diabetes, recent weight gain (within one year prior to diagnosis) predicts subsequent weight loss after diagnosis, whereas long-term historical weight history (weight at age 20 or changes 10 years prior) does not predict post-diagnosis weight changes.

If you have recently gained weight leading up to a type 2 diabetes diagnosis, you are statistically likely to lose weight after diagnosis compared to those who were stable or losing weight. However, your weight at age 20 or your weight trends from 10 years ago do not predict your post-diagnosis weight. Focus on your current trajectory and recent changes rather than your distant history.

Higher BMI at the time of diabetes diagnosis is a significant predictor of greater weight loss during the first 6 years following diagnosis.

If you are diagnosed with type 2 diabetes and have a higher BMI, you can expect to lose more weight in the first few years after diagnosis than those with a lower BMI. This is a common trend observed in clinical practice and is not a failure of willpower, but a physiological response to the diagnosis and treatment.

Type 2 diabetes exaggerates physiological exercise effort (lactate and heart rate) and impairs exercise performance in older women, creating a barrier to physical activity adherence.

If you have Type 2 Diabetes, exercise may feel harder than it does for others, even at low intensities. This is a physiological reality, not a lack of willpower. To stay active, prioritize comfort over intensity. Start with low-intensity activities that feel manageable, as this approach builds adherence and fitness without triggering excessive fatigue or negative feelings about exercise.

Adding culinary spices to high-sugar foods (e.g., apple crisp) can preserve hedonic liking and consumption levels despite a significant reduction (up to 37%) in added sugar, effectively substituting sweetness with complex flavor profiles.

If you want to cut sugar in desserts like apple crisp or baked goods, don't just remove the sugar; add spices like cinnamon, ginger, or vanilla. This study shows that for high-sugar foods, spices can mask the loss of sweetness and keep the taste just as good as the full-sugar version. However, this trick doesn't work well for simple foods like tea or plain oatmeal, where sweetness is the main flavor. Focus on complex, sugary foods when using this strategy.

Replacing saturated fatty acids (SFA) with polyunsaturated (PUFA) or monounsaturated fatty acids (MUFA) reduces serum HDL-C, whereas replacing carbohydrates with these fatty acids increases HDL-C.

If you want to raise your HDL-C through diet, replacing carbohydrates (especially refined carbs) with unsaturated fats (like olive oil or nuts) is more effective than replacing saturated fats (like butter) with those same unsaturated fats. However, remember that HDL-C is just a number; the functional quality of your HDL particles is what ultimately matters for heart health.

Smoking reduces HDL-C concentrations by approximately 6%, and smoking cessation reverses this reduction, raising HDL-C by about 0.10 mmol/L.

Quit smoking. Your HDL-C will likely increase by about 0.10 mmol/L. Be aware that nicotine replacement therapy (patches/gum) might delay this HDL recovery; stopping the nicotine itself allows HDL to normalize. The benefit of quitting outweighs potential weight gain.

Persistent metabolic syndrome (MetS) and the development of MetS over time are associated with a significantly increased risk of incident atrial fibrillation (AF), with risk increasing proportionally to the number of MetS components.

Maintaining metabolic health is critical for preventing atrial fibrillation. If you have metabolic syndrome (high blood pressure, high blood sugar, high triglycerides, low HDL, or abdominal obesity), your risk of AF is significantly higher. Even if you improve your metabolic health later, your risk remains higher than someone who was always metabolically healthy, though it is lower than if you had kept the syndrome. The best strategy is to prevent MetS from developing in the first place, especially if you are young or middle-aged.

The association between metabolic syndrome status changes and atrial fibrillation risk is significantly stronger in younger (20-39 years) and middle-aged (40-64 years) populations compared to the elderly (≥65 years).

If you are under 65, managing your metabolic health (weight, blood pressure, blood sugar) is even more critical for preventing atrial fibrillation than it is for those over 65. The risk of AF from metabolic syndrome is much higher in younger and middle-aged adults. Preventing metabolic syndrome early in life offers the greatest protection against AF.

Inappropriate physical activity (low physical activity) is associated with a higher prevalence of dyslipidemia, with an odds ratio of 1.2 compared to those with appropriate physical activity.

Increasing your physical activity levels can help improve your lipid profile. Aim for at least 150 minutes of moderate-intensity activity per week, as recommended by general health guidelines, to reduce your risk of dyslipidemia.

Resistance training interventions introduce significant interindividual response variation (heterogeneity) in strength and hypertrophy outcomes beyond random measurement error, as evidenced by increased variance in change scores compared to non-training controls.

Do not assume that a resistance training program that works for others will work identically for you. The paper confirms that resistance training introduces significant individual variability in strength and muscle growth. If you are not progressing, it may be due to your specific 'trainability' or response pattern rather than poor adherence. Consider that personalized adjustments to volume, intensity, or exercise selection may be necessary, as 'one size fits all' prescriptions are statistically less likely to optimize individual outcomes.

Acarbose and metformin provide similar HbA1c reduction and modest weight loss in newly diagnosed Chinese type 2 diabetic patients regardless of BMI status.

For newly diagnosed Chinese type 2 diabetics, both acarbose (300mg/day) and metformin (1500mg/day) are effective first-line treatments for lowering HbA1c and achieving modest weight loss, regardless of whether you are normal weight, overweight, or obese. Acarbose may offer slightly better weight loss in overweight individuals, while metformin may be better for fasting blood glucose. The choice depends on individual tolerance and dietary habits, particularly carbohydrate intake.

In overweight patients, metformin is superior to acarbose for lowering fasting blood glucose, while acarbose is superior to metformin for lowering 2-hour post-challenge blood glucose.

If you are overweight and newly diagnosed with type 2 diabetes, metformin may be better for controlling your fasting blood sugar, while acarbose may be better for controlling your blood sugar after meals. This allows for personalized treatment based on your specific glucose profile.

Metformin is superior to acarbose for improving insulin resistance in normal weight patients, while both drugs are similar in overweight and obese patients.

If you are normal weight and newly diagnosed with type 2 diabetes, metformin may be a better choice than acarbose for improving your body's sensitivity to insulin.

GLP-1 receptor agonists provide significant cardiovascular benefits, including reduced risk of major adverse cardiovascular events (MACE) and stroke, in addition to weight loss and glycemic control.

GLP-1 agonists (like Ozempic or Victoza) do more than lower blood sugar and help with weight loss. They have been proven to reduce the risk of heart attacks, strokes, and cardiovascular death in people with Type 2 Diabetes. If you have heart disease or risk factors, these drugs may offer significant protection beyond just sugar control.

Lifestyle behaviors (smoking cessation, weight reduction, physical activity, sodium restriction) are the core management strategy for cardiovascular risk in women with diabetes, despite limited randomized trial evidence for mortality reduction.

Focus on smoking cessation, weight loss, regular physical activity (30+ mins/day), and dietary changes (low sodium, high fruits/vegetables). These are the most important steps for reducing heart disease risk in diabetes, even if they don't always show immediate mortality benefits in trials.